MAPT and Down syndrome: Additionally, these authors found “more rapid onset of tau pathology relative to amyloid plaque presence, as well as a greater magnitude of tau burden relative to amyloid, [which] suggests a shorter overall time course for Alzheimer’s disease pathological progression in people with Down syndrome compared with autosomal-dominant Alzheimer’s disease”.